| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4756273
Max Phase: Preclinical
Molecular Formula: C21H20N4O5S
Molecular Weight: 440.48
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(CNS(=O)(=O)c1ccccc1C(=O)NCc1ccccn1)Nc1ccc(O)cc1
Standard InChI: InChI=1S/C21H20N4O5S/c26-17-10-8-15(9-11-17)25-20(27)14-24-31(29,30)19-7-2-1-6-18(19)21(28)23-13-16-5-3-4-12-22-16/h1-12,24,26H,13-14H2,(H,23,28)(H,25,27)
Standard InChI Key: YXIQZDGOFYNLFU-UHFFFAOYSA-N
Associated Targets(Human)
Hepatocyte 2737 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 440.48 | Molecular Weight (Monoisotopic): 440.1154 | AlogP: 1.63 | #Rotatable Bonds: 8 |
| Polar Surface Area: 137.49 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.13 | CX Basic pKa: 4.14 | CX LogP: 1.07 | CX LogD: 1.07 |
| Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.39 | Np Likeness Score: -1.92 |
References
| 1. Bazan HA,Bhattacharjee S,Burgos C,Recio J,Abet V,Pahng AR,Jun B,Heap J,Ledet AJ,Gordon WC,Edwards S,Paul D,Alvarez-Builla J,Bazan NG. (2020) A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis., 202 [PMID:32629335] [10.1016/j.ejmech.2020.112600] |
Source
Source(1):